Table 3 ORs and 95% CIs of ovarian cancer and borderline tumours according to CA125 by age groups
From: BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study
Ovarian cancer | Borderline tumour | |||
|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | |
All | ||||
CA125 positive | ||||
Case less than 40 years old | 1.1 | 0.3–3.5 | 0.8 | 0.2–3.0 |
Case 40–49 years old | 3.5 | 2.3–5.4 | 2.8 | 1.6–4.8 |
Case 50+ years old | 3.3 | 1.5–7.1 | 12 | 1.3–110 |
CA125 measurements less than five years prior to diagnosis | ||||
CA125 positive | ||||
Case less than 40 years old | — | — | 4.4 | 0.4–51 |
Case 40–49 years old | 4.3 | 2.1–8.8 | 6.6 | 2.7–16 |
Case 50+ years old | 5.2 | 1.9–14 | 3.0 | 0.2–48 |
